Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo - PubMed (original) (raw)
Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo
F Plata et al. Cell. 1987.
Abstract
We have initiated the molecular definition of the antigens recognized by Gross MuLV-specific cytolytic T lymphocytes on the surface of Gross MuLV-induced tumor cells. A panel of target cells was obtained by the double transfection and expression of a retrovirus gene and a foreign H-2 gene in recipient mouse fibroblasts. Our results show that class I H-2 transplantation antigens have a directive influence in determining the antigenicity of proteins encoded by the gag and env MuLV genes. Genes not linked to H-2 influence the intensity and the specificity of the cytolytic T lymphocyte response to Gross MuLV-induced tumors. Finally, MuLV-induced antigens expressed by transfected fibroblasts induce tumor immunity and lead to accelerated tumor rejection in vivo.
Similar articles
- Resistance to cellular immune response in AKR leukemias.
Schäfer A, Schmidt W. Schäfer A, et al. Eur J Immunol. 1986 Jul;16(7):753-9. doi: 10.1002/eji.1830160707. Eur J Immunol. 1986. PMID: 2424771 - Molecular definition of retrovirus-induced antigens recognized by tumour-specific H-2-restricted cytolytic T lymphocytes.
Plata F, Langlade-Demoyen P, Abastado JP, Berbar T, Kourilsky P. Plata F, et al. J Immunogenet. 1986 Apr-Jun;13(2-3):263-8. doi: 10.1111/j.1744-313x.1986.tb01110.x. J Immunogenet. 1986. PMID: 3493297 - Natural immunity to endogenous oncornaviruses in mice.
Ihle JN, Hanna MG Jr. Ihle JN, et al. Contemp Top Immunobiol. 1977;6:169-74. doi: 10.1007/978-1-4684-3051-6_5. Contemp Top Immunobiol. 1977. PMID: 194747 Review. No abstract available. - Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivo.
van der Hoorn FA, Lahaye T, Müller V, Ogle MA, Engers HD. van der Hoorn FA, et al. J Exp Med. 1985 Jul 1;162(1):128-44. doi: 10.1084/jem.162.1.128. J Exp Med. 1985. PMID: 3891902 Free PMC article. Review.
Cited by
- Immunogenic determinants of a neuropathogenic murine leukemia virus.
Robbins DS, Remington MP, Sarzotti M, St Louis D, Hoffman PM. Robbins DS, et al. J Virol. 1995 Nov;69(11):6847-51. doi: 10.1128/JVI.69.11.6847-6851.1995. J Virol. 1995. PMID: 7474098 Free PMC article. - 5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses.
Goodenow MM, Hayward WS. Goodenow MM, et al. J Virol. 1987 Aug;61(8):2489-98. doi: 10.1128/JVI.61.8.2489-2498.1987. J Virol. 1987. PMID: 3037111 Free PMC article. - FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP, Kern DE, Okuno K, Holt C, Lilly F, Greenberg PD. Klarnet JP, et al. J Exp Med. 1989 Feb 1;169(2):457-67. doi: 10.1084/jem.169.2.457. J Exp Med. 1989. PMID: 2562982 Free PMC article. - Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy.
Gong P, Wang Y, Zhang P, Yang Z, Deng W, Sun Z, Yang M, Li X, Ma G, Deng G, Dong S, Cai L, Jiang W. Gong P, et al. Cancers (Basel). 2020 Dec 30;13(1):77. doi: 10.3390/cancers13010077. Cancers (Basel). 2020. PMID: 33396603 Free PMC article. Review.